Copyright
©The Author(s) 2020.
World J Gastroenterol. Jun 7, 2020; 26(21): 2810-2820
Published online Jun 7, 2020. doi: 10.3748/wjg.v26.i21.2810
Published online Jun 7, 2020. doi: 10.3748/wjg.v26.i21.2810
Figure 1 Gan Shen Fu Fangdecreased serum levels of alanine aminotransferase, aspartate aminotransferase and total bilirubin in common bile duct-ligated rats and the liver and spleen coefficients (n = 8).
A: Alanine aminotransferase level; B: Aspartate aminotransferase level; C: Total bilirubin level; D:Liver coefficient; E: Spleen coefficient. The data are presented as the mean ± SD. bP < 0.01, eP < 0.001, compared with the sham group; cP < 0.05, compared with the 2W-CBDL rats; gP < 0.05, kP < 0.001, compared with the 4W-CBDL rat. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TBIL: Total bilirubin; CBDL: Common bile duct-ligated; GSFF: Gan Shen Fu Fang.
- Citation: Du QH, Zhang CJ, Li WH, Mu Y, Xu Y, Lowe S, Han L, Yu X, Wang SY, Li Y, Li J. Gan Shen Fu Fang ameliorates liver fibrosis in vitro and in vivo by inhibiting the inflammatory response and extracellular signal-regulated kinase phosphorylation. World J Gastroenterol 2020; 26(21): 2810-2820
- URL: https://www.wjgnet.com/1007-9327/full/v26/i21/2810.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i21.2810